Mereo BioPharma (MREO) Debt Ratio (2017 - 2020)

Mereo BioPharma (MREO) has reported Debt Ratio for 4 consecutive years, with 0.25 the latest figure, recorded in Q2 2020.

• Quarterly Debt Ratio rose 37.3% year-over-year to 0.25 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was 0.25 (up 37.3% YoY) and the FY2022 annual result came in at 0.17, changed N/A from the prior year.
• Debt Ratio rose to 0.25 in Q2 2020 per MREO's latest filing, from 0.24 in the prior quarter.
• Over the last five years, Debt Ratio for MREO reached as high as 0.32 in Q4 2018 and fell as low as 0.18 in Q2 2019.
• A 4-year average of 0.24 and a median of 0.24 in 2019 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2018 — Debt Ratio jumped 48.25% — and 2019, when it dropped 25.7%.
• Year by year, Debt Ratio stood at 0.22 in 2017, then soared by 48.25% to 0.32 in 2018, then dropped by 25.7% to 0.24 in 2019, then climbed by 6.57% to 0.25 in 2020.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.25, 0.24, and 0.18 for Q2 2020, Q4 2019, and Q2 2019 respectively.